MedTrace Logo

Stress Management Therapy for Meniere's Disease

NCT01099046 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2010-04-06

No results posted yet for this study

Summary

Attacks in Meniere's disease, characterized by vertigo and hearing loss, are well known to occur repeatedly under stressed environment. Hitherto, its pathology was revealed to be inner ear hydrops through human temporal bone studies in 1938. For the pathogenesis of inner ear hydrops resulting in Meniere's attacks, plasma vasopressin elevation due to stress and V2 receptor overexpression in the inner ear could be essential as a basis of this disease. In the present study, we'd like to find the effective and feasible way to reduce plasma vasopressin level in patients with Meniere's disease.

Conditions

  • Meniere's Disease
  • Stress

Interventions

BEHAVIORAL

Lifestyle

water intake, tympanic tubing, regular sleep

Sponsors & Collaborators

  • Osaka University

    lead OTHER

Principal Investigators

  • Tadashi Kitahara, M.D.,Ph.D. · Department of Otolaryngology, Osaka University, School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2015-01-31
Completion
2020-01-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01099046 on ClinicalTrials.gov